Patients On Chemotherapy Who Have Heart Disease: Barry Ramo
Transcription
Patients On Chemotherapy Who Have Heart Disease: Barry Ramo
4/9/2015 Cardio-Oncology for the Primary Care Provider as a result of the treatment. Barry W. Ramo, MD,FACC New Mexico Heart Institute April 11, 2015 what is the least likely cause of death for a patient who has survived one cancer? 1. Cancer 2. Heart Disease what is the most likely cause of death for a patient who has survived cancer? 1. Cancer 2. Heart Disease Cancer patients are cured of one life-threatening disease, only to succumb to another — heart failure — 1 4/9/2015 Cardiac Care of Patients with Cancer CV Evaluation, Risk Factors Survival Cancer Diagnosis. Cytotoxic Rx Targeted XRT Cardiac Care • Cardiac • CV Toxicity disease • Strain • Premature ,EF,Biomar death ker • MRI Primary Care Provider Role in Caring for their Patients with Cancer Diagnosis During Therapy Post Therapy Therapeutic and Cardiotoxic Agents Type 1 Anthrcyclines Type 2 Herceptin TARGETED THERAPY • Tyrosine Kinase inhibitors • VEGF Inhibitors 2 4/9/2015 Conflicting Goals Maximize therapeurtic benefit Kill the Prevent cancer Cancer therapeutics related cardiac dysfunction (CTRCD) Detection of Early Toxicity • Biomarkers: BNP, Troponin • Left ventricular dysfunction • Cardiac MR Detection of Risk for Deterioration of Cardiac Function after anthracyclines and Herceptin • Predictors at 3 months HS Troponin Myocardial strain • Not Predictive • BNP • Ejection Fraction 3 4/9/2015 Prevention of Cardiotoxicty • Limited Data • Beta Blocker, ACE-I combination in small studies reduced LV dsyfunction Iib recommendation OVERDRIVE: EnalapriI + Carvedilol With intensive Chemotherapy . N=90 Mortality 6% Mortality 22% 6.2% 33% Cardiac Care of Patients with Cancer CV Evaluation, Risk Factors Cardiac Care Survival Cancer Diagnosis. Cytotoxic Rx Targeted XRT • • • Cardiac Toxicity Strain ,EF,Bioma rker MRI • Late heart failure • HBP • Optimize Risk Factors 4 4/9/2015 Thank You 5
Similar documents
US Cardiac Rhythm Management Devices Market - Upcoming Opportunities and New Trends
The latest report, “United States Cardiac Rhythm Management Devices Market Outlook to 2021”, provides key market data on the United States Cardiac Rhythm Management Devices market. The report provides value, in millions of US dollars, volume (in units) and average price data (in US dollars), within market segments – Cardiac Resynchronisation Therapy (CRT), Implantable Cardioverter Defibrillators (ICD), Implantable Loop Recorders (ILR) and Pacemakers.
More information